<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Hum Mol Genet</journal-id>
<journal-id journal-id-type="iso-abbrev">Hum. Mol. Genet</journal-id>
<journal-id journal-id-type="publisher-id">hmg</journal-id>
<journal-id journal-id-type="hwp">hmg</journal-id>
<journal-title-group>
<journal-title>Human Molecular Genetics</journal-title>
</journal-title-group>
<issn pub-type="ppub">0964-6906</issn>
<issn pub-type="epub">1460-2083</issn>
<publisher>
<publisher-name>Oxford University Press</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">27340224</article-id>
<article-id pub-id-type="pmc">5179921</article-id>
<article-id pub-id-type="doi">10.1093/hmg/ddw168</article-id>
<article-id pub-id-type="publisher-id">ddw168</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Differential molecular and behavioural alterations in mouse models of <italic><italic>GABRG2</italic></italic> haploinsufficiency versus dominant negative mutations associated with human epilepsy</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Warner</surname>
<given-names>Timothy A.</given-names>
</name>
<xref ref-type="aff" rid="ddw168-aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Shen</surname>
<given-names>Wangzhen</given-names>
</name>
<xref ref-type="aff" rid="ddw168-aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Xuan</given-names>
</name>
<xref ref-type="aff" rid="ddw168-aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Liu</surname>
<given-names>Zhong</given-names>
</name>
<xref ref-type="aff" rid="ddw168-aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Macdonald</surname>
<given-names>Robert L.</given-names>
</name>
<xref ref-type="aff" rid="ddw168-aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ddw168-aff2">
<sup>2</sup>
</xref>
<xref ref-type="aff" rid="ddw168-aff3">
<sup>3</sup>
</xref>
<xref ref-type="aff" rid="ddw168-aff5">
<sup>5</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Jing-Qiong</given-names>
</name>
<xref ref-type="aff" rid="ddw168-aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="ddw168-aff5">
<sup>5</sup>
</xref>
<xref ref-type="corresp" rid="ddw168-cor1">*</xref>
</contrib>
<aff id="ddw168-aff1"><label>1</label>Departments of Neurology</aff>
<aff id="ddw168-aff2"><label>2</label>Molecular Physiology and Biophysics</aff>
<aff id="ddw168-aff3"><label>3</label>Pharmacology</aff>
<aff id="ddw168-aff4"><label>4</label>The Graduate Program of Neuroscience</aff>
<aff id="ddw168-aff5"><label>5</label>The Vanderbilt Brain Institute, Vanderbilt University Medical Center Nashville, TN 37212, USA</aff>
</contrib-group>
<author-notes>
<corresp id="ddw168-cor1"><label>*</label>To whom correspondence should be addressed at: Vanderbilt University Medical Center, 6140 Medical Research Building III 465 21st Ave, South, Nashville, TN 37232-8552, USA. Tel: +615 936 8399; Fax: +615 322 5517; Email: <email>jingqiong.kang@vanderbilt.edu</email></corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>01</day>
<month>8</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="epub">
<day>23</day>
<month>6</month>
<year>2016</year>
</pub-date>
<volume>25</volume>
<issue>15</issue>
<fpage>3192</fpage>
<lpage>3207</lpage>
<history>
<date date-type="received">
<day>22</day>
<month>3</month>
<year>2016</year>
</date>
<date date-type="rev-recd">
<day>19</day>
<month>5</month>
<year>2016</year>
</date>
<date date-type="accepted">
<day>23</day>
<month>5</month>
<year>2016</year>
</date>
</history>
<permissions>
<copyright-statement>© The Author 2016. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com</copyright-statement>
<copyright-year>2016</copyright-year>
</permissions>
<abstract>
<p>Genetic epilepsy is a common disorder with phenotypic variation, but the basis for the variation is unknown. Comparing the molecular pathophysiology of mutations in the same epilepsy gene may provide mechanistic insights into the phenotypic heterogeneity. <italic><italic>GABRG2</italic></italic> is an established epilepsy gene, and mutations in it produce epilepsy syndromes with varying severities. The disease phenotype in some cases may be caused by simple loss of subunit function (functional haploinsufficiency), while others may be caused by loss-of-function plus dominant negative suppression and other cellular toxicity. Detailed molecular defects and the corresponding seizures and related comorbidities resulting from haploinsufficiency and dominant negative mutations, however, have not been compared<italic>.</italic> Here we compared two mouse models of <italic><italic>GABRG2</italic></italic> loss-of-function mutations associated with epilepsy with different severities, <italic>Gabrg2<sup>+/Q390X</sup></italic> knockin (KI) and <italic>Gabrg2<sup>+/-</sup></italic> knockout (KO) mice. Heterozygous <italic>Gabrg2<sup>+/Q390X</sup></italic>KI mice are associated with a severe epileptic encephalopathy due to a dominant negative effect of the mutation, while heterozygous <italic>Gabrg2<sup>+/-</sup></italic> KO mice are associated with mild absence epilepsy due to simple haploinsufficiency. Unchanged at the transcriptional level, KI mice with severe epilepsy had neuronal accumulation of mutant <italic>γ</italic>2 subunits, reduced remaining functional wild-type subunits in dendrites and synapses, while KO mice with mild epilepsy had no intracellular accumulation of the mutant subunits and unaffected biogenesis of the remaining wild-type subunits. Consequently, KI mice with dominant negative mutations had much less wild-type receptor expression, more severe seizures and behavioural comorbidities than KO mice. This work provides insights into the pathophysiology of epilepsy syndrome heterogeneity and designing mechanism-based therapies.</p>
</abstract>
<counts>
<page-count count="16"></page-count>
</counts>
</article-meta>
</front>
</article>
</pmc-articleset>